|
Site Search
|
RHEI Licenses China Rights to ADHA Nutraceutical
publication date: Feb 20, 2008
RHEI Pharmaceuticals, Inc., a US company that seeks to bring proprietary medications to China, licensed the China marketing rights for Attental from MethaPharma. Attental is a nutraceutical drug available in Europe to treat symptoms of ADHD in children. MethaPharma, a division of Vemedia Group, is headquartered in Belgium. More details...
|
Partner Events
October 11-13, 2008
Dalian, China
U.S. FDA Inspections in China
October 15, 2008
China
November 8, 2008
San Diego, CA
November 9-11, 2008
Shanghai, China
February 23-25, 2009
San Diego
>> More details...
|
